烯硫胺作为选择性碳酸无水酶I,IX和XII抑制剂
Toni C Denner1, Andrea Angeli2, Marta Ferraroni3
1Organic Chemistry, Martin-Luther University Halle-Wittenberg, Kurt-Mothes, Str. 2, D-06120 Halle (Saale), Germany.
Molecules (Basel, Switzerland)
|December 9, 2023
概括
新的硫胺体现出对碳酸无水酶 (CA) 的强烈抑制. 双和基替代化合物选择性地向与癌症相关的CA IX和XII,其中一种化合物对CA XII具有很高的亲和力.
科学领域:
- 药用化学 医学化学
- 酶抑制可以抑制酶.
- 药物发现 药物发现 药物发现
背景情况:
- 硫胺是关键的药物类别,具有显著的碳酸胺酶抑制特性.
- 碳酸 anhydrases (CA) 涉及到各种生理过程和疾病,包括癌症和.
研究的目的:
- 合成新型硫胺基并评估它们对人类碳酸无水酶 (hCA) 的抑制潜力.
- 确定针对癌症和瘤相关的特定CA异型的选择性抑制剂.
主要方法:
- 合成各种双和基替代的硫胺.
- 在体外酶分析以确定对hCA I,hCA II,hCA IX和hCA XII的抑制活性和选择性.
- 强效化合物的抑制常数 (Ki) 的确定.
主要成果:
- 几种合成的硫胺体现出对碳酸无水酶的显著抑制活性.
- 双和基替代的硫胺显示出对hCA IX和hCA XII的高选择性.
- 化合物3 (4-[3-(2-基) 化物]二硫胺) 显示出相对于hCA XII的1.0nM的显著低的Ki值.
- 观察到一些化合物对hCA I具有显著的抑制活性.
结论:
- 新型硫胺物具有对碳酸无水酶有前途的抑制特征.
- 选择性抑制hCA IX和hCA XII突出显示了在低氧性癌症中的潜在治疗应用.
- 针对hCA I的化合物可能为诸如脑等疾病提供未来的治疗途径.
更多相关视频
相关概念视频
Antihypertensive Drugs: Thiazide-Class Diuretics
669
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
669
Antihypertensive Drugs: Direct Renin Inhibitors
632
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
632
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
648
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
648
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
487
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
487
Renal Drug Excretion: Tubular Secretion
192
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
192
Drug Elimination by Renal Route: Tubular Secretion
2.4K
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.4K


